Optimizing Depression Management in Pharmacy Practice

CAN-eng

$0

free

CCCEP,OPQ

30 min

Mental Health

0.75 Credits

Course Description

Depression (MDD*) can significantly affect an individual’s health, leading to social and occupational impairment, diminished self-management of comorbidities, diminished quality of life, and an elevated risk of death by suicide. This program supports clinicians in effectively identifying and managing depression in their patients.

The program will review the signs and symptoms of depression, discuss a range of treatment options, including both pharmacological and non-pharmacological approaches. By the end of the session, clinicians will be better prepared to deliver comprehensive and effective care to patients with depression.

* Major Depressive Disorder

Course Details

Expiry Date: 2025-10-03
Professions: Pharmacy

Faculty

  • Daniel Mueller, MD, PhD
  • Chandi Chandrasena, MD, CCFP, FCFP
  • Javed Alloo, MD, CCFP, MPLc
  • Jeff Habert, MD, CCFP, FCFP
  • Betty Golightly, B.Sc. (Pharm), RPh
  • John Papastergiou, BSc, BScPhm, PhD, RPh

Accreditation

This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 0.75 CEU(s).
CCCEP File Number: 1066-2024-3851-I-P

This continuing educational activity has been accredited by the OPQ; 0.5 continuing education units/credits will be awarded to pharmacists who successfully complete the program. 

Accreditation number: 240128

Learning Objectives

Upon completion of this continuing education program participants will be better able to:

  • Describe the common signs and symptoms of MDD
  • Compare the different antidepressant classes and adjunctive therapies by their role in therapy, tolerability, and efficacy
  • Discuss approaches and tools to achieve symptom remission
  • Review non-pharmacological treatment options and their role in therapy

CCCEP
Accredited
Course

OPQ
Accredited
Course